悦康药业集团股份有限公司关于公司董事、高级管理人员离任暨补选职工董事的公告

Core Viewpoint - The announcement details the resignation of two key personnel at Yuyuan Pharmaceutical Group Co., Ltd., including the election of a new employee representative director, ensuring compliance with legal regulations and maintaining board functionality [1][3]. Group 1: Resignation of Directors and Senior Management - Zhang Wei, the employee representative director, resigned for personal reasons but will remain with the company [1]. - Yang Lei, the deputy general manager, resigned due to work adjustments but will also continue to work at the company [1]. - Both resignations will not affect the normal operations of the company, as they have completed the necessary handover procedures [2]. Group 2: Election of Employee Representative Director - On February 13, 2026, Yang Lei was elected as the employee representative director for the third board of directors, with a term lasting until the end of the current board's term [3]. - Yang Lei meets all qualifications and conditions required by relevant laws and the company's articles of association to serve as a director [3]. - The number of directors who are also senior management and employee representative directors does not exceed half of the total board members, complying with legal and regulatory requirements [3].